ClinicalTrials.Veeva

Menu

Registry of Local Recurrences After Breast-conserving Surgery (R_ReLoCC)

U

Universidade do Porto

Status

Not yet enrolling

Conditions

Breast Cancer Recurrent

Study type

Observational

Funder types

Other

Identifiers

NCT05406661
R_ReLoCC

Details and patient eligibility

About

The ReLoCC project is a prospective, multicenter, clinical study to register cases of local recurrence after breast-conserving surgery, in centers dedicated to the treatment of breast cancer, in Portugal and Spain.

The comparison of the results obtained will allow the optimization of the treatment, making it increasingly personalized.

Enrollment

3,000 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Female patients

  2. Age > 18 years

  3. Patients who have previously undergone breast-conserving surgery as part of the treatment of invasive or non-invasive (in situ) breast cancer

    1. and adjuvant breast RT: total (WBI) or partial (PBI)
    2. without adjuvant radiotherapy to the breast
  4. Recent histological diagnosis of homolateral, invasive or non-invasive (in situ) breast carcinoma

Exclusion criteria

  1. Male
  2. Age < 18 years
  3. Stage 4 at diagnosis
  4. Patients operated outside the participating Centers and for whom it is not possible to obtain complete information regarding the primary treatment
  5. History of other primary invasive malignant tumor (except non-melanoma skin carcinomas)
  6. Patients already treated for another local recurrence of breast carcinoma
  7. Absence of clinical follow-up and records in clinical process

Trial contacts and locations

0

Loading...

Central trial contact

Janete Santos, PhD; Diana Gonçalves, MD, PhDc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems